ABOUT
EVENTS
CLINICAL PRACTICE
- Clinical practice activities
- ESPE Funding
EDUCATION
GRANTS & AWARDS
PUBLICATIONS
MEMBERS

✕

Annual Review 2019

Home
Publications
Annual review
Annual Review 2019

Untitled-3

Issue 1 – Summer 2005

A GH Secretagogue Receptor Agonist (LUM-201) Elicits Greater GH Responses than Standard GH Secretagogues in Subjects of a Pediatric GH Deficiency Trial

Recurrent Intracranial Hypertension in a Toddler with Graves’ Disease

The 2021 European Training Requirements in Paediatric Endocrinology and Diabetes

Invaluable Role of Consanguinity in Providing Insight into Paediatric Endocrine Conditions: Lessons Learnt from Congenital Hyperinsulinism, Monogenic Diabetes, and Short Stature

The Timing of Genital Surgery in Somatic Intersexuality: Surveys of Patients’ Preferences

Twice Daily Compared to Three Times Daily Hydrocortisone in Prepubertal Children with Congenital Adrenal Hyperplasia

ISSUE 57 /AUTUMN 2022

Growth Hormone and Insulin-Like Growth Factor Dysregulation in Pediatric Chronic Kidney Disease

The Impact of Hypo- and Hyperglycemia on Cognition and Brain Development in Young Children with Type 1 Diabetes

Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study

Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Reduced in Euthyroid Children with Newly Diagnosed Hashimoto’s Thyroiditis: A Pilot Study

Uncoupling of the Infancy Life History Stage

Is Gadolinium Contrast Necessary for Pituitary MRI in the Evaluation of Pediatric Short Stature and Growth Hormone Deficiency?

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Macimorelin in Children with Suspected Growth Hormone Deficiency: An Open-Label, Group Comparison, Dose-Escalation Trial

Follow-Up Study of Growth Hormone Therapy in Children with Kabuki Syndrome: Two-Year Treatment Results

Increased Prevalence of Beta-Cell Dysfunction despite Normal HbA1c in Youth and Young Adults with Turner Syndrome

Normal Mid-Gestation Fetal Ultrasonography Cannot Reliably Exclude Severe Perinatal Hypophosphatasia

Assessment of Serum Spexin Levels in Obese Adolescents with Metabolic Syndrome Antecedents: Preliminary Results

Lethal Encephalopathy in an Infant with Hypophosphatasia despite Enzyme Replacement Therapy

When Is a Positive Test for Pediatric Growth Hormone Deficiency a True-Positive Test?

Obesity as a Thrombogenic and Cardiovascular Risk Factor in Children

Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion

Age-Related Association of Calcitonin with Parameters of Anthropometry, Bone and Calcium Metabolism during Childhood

Long-Term Effectiveness and Safety of Childhood Growth Hormone Treatment in Noonan Syndrome

Clinical Characteristics, Molecular Features, and Long-Term Follow-Up of 15 Patients with Neonatal Diabetes: A Single-Centre Experience

Cortisol and Cortisone in Early Childhood in Very-Low-Birthweight Infants and Term-Born Infants

Postoperative and Long-Term Endocrinologic Complications of Craniopharyngioma

Post-Transplantation Diabetes Mellitus in Pediatric Patients

Annual review

Improving the clinical care of children and adolescents with endocrine conditions, including diabetes, through research and education.

Company limited by guarantee. Registered in England & Wales. Company No: 5766541. Charity No: 1122484. Registered Office: 65 Carter Lane, London EC4V 5HF, United Kingdom.

Navigation

Home
Events
Patient Links
Contact Us
News Alert Registration

Information

Privacy Policy & Cookies
Terms and Conditions
Accessibility

This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.

Read more